Electroacupuncture at Baliao Points Attenuates Visceral Hypersensitivity in Irritable Bowel Syndrome via Gut-Microbiota-Mast Cell-TPRV1 Axis Modulation.

Researchers have discovered how electroacupuncture at specific points called Baliao may help relieve chronic abdominal pain in people with irritable bowel syndrome (IBS). The study included 40 IBS patients aged 30-60 who received electroacupuncture treatment, alongside laboratory research using an animal model to understand the biological mechanisms involved.

The study found that electroacupuncture at Baliao points significantly reduced pain levels in IBS patients and decreased visceral hypersensitivity—the heightened pain response in the digestive system that makes IBS so uncomfortable. The researchers discovered that this treatment works through multiple pathways in the body. It helps restore healthy gut bacteria by increasing beneficial microbes like Bifidobacterium and Akkermansia while reducing harmful ones. The treatment also calmed down overactive mast cells (immune cells that release pain-triggering chemicals) and strengthened the intestinal barrier that protects against irritation.

Perhaps most importantly, the study showed that electroacupuncture blocks pain signals by affecting TRPV1 neurons—specialized nerve cells that transmit pain sensations from the gut to the brain. By reducing the release of inflammatory substances like histamine (by 40%) and substance P (by 28%), and by interrupting the communication between immune cells and pain nerves, electroacupuncture appears to address multiple root causes of IBS pain simultaneously.

For patients considering acupuncture for IBS, these findings suggest that electroacupuncture targeting the Baliao points may offer meaningful relief from chronic abdominal pain without medication. The treatment appears to work by addressing the underlying biological problems rather than just masking symptoms. If you're interested in trying this approach, seek a licensed acupuncturist trained in electroacupuncture techniques and experienced in treating digestive disorders.

This translational study (n=40 IBS patients, gender-balanced, ages 30-60) demonstrates that electroacupuncture at Baliao acupoints significantly attenuates visceral hypersensitivity through a gut-microbiota-mast cell-TRPV1 axis. In the clinical cohort, EA reduced VAS pain scores (difference -3.000±0.4264). The rat model showed decreased AWR scores (difference 1.050±0.2630) compared to sham. Mechanistically, EA restored gut microbial diversity (increased Bifidobacterium, Akkermansia; decreased Helicobacter, Prevotella via 16S rDNA sequencing), inhibited mast cell degranulation (histamine ↓40%, p<0.01; substance P ↓28%, p<0.05), enhanced intestinal barrier integrity (upregulated ZO-1/occludin), and suppressed TRPV1+ neuron activation in colonic tissue and DRG. Western blot analysis confirmed modulation of TRPV1/MAPK signaling pathways. Treatment duration was 2 weeks. Clinical takeaway: EA at Baliao represents a multi-mechanistic, non-pharmacological intervention for IBS-related visceral pain, targeting microbiome dysbiosis, immune activation, and nociceptive signaling simultaneously.